News

Sustaining a burn that lands a patient in the hospital may have long-term implications for their risk of acquiring infectious diseases later on.

A team from Duke University’s Developing World Healthcare Technologies Lab have discovered a way to extend the lifespan of antiretroviral drugs in order to prevent mother-to-child HIV transmission in developing countries.

An alternative treatment option for treating and preventing Pneumocystis jiroveci pneumonia may be in the horizon for patients who cannot tolerate the standard therapy.

With cases of antibiotic-resistant gonorrhea on the rise, researchers from the University of York may have made a breakthrough in the quest to find treatments that work.

New surveillance reports from the Centers for Disease Control and Prevention (CDC) show that this year’s influenza vaccine can offer effective protection against circulating viruses this flu season.

Derek Gatherer, PhD, lecturer at Lancaster University has compiled a list of emerging diseases to watch out for in 2017.

The year 2016 may be over, but the fight against the infectious disease that dominated headlines for most of the year—Zika virus—has only just begun.

Your cash is probably dirtier than you think, with the potential to serve as a vehicle for a number of harmful, disease-causing bacteria.

Research on a patient with acute myeloid leukemia has revealed new information on how bacteria mutate to survive antibiotics.

With the opening of a new R&D center in Rockville, MD, GlaxoSmithKline strives to improve global outbreak preparedness and calls for increased vaccine production capacity.

While more information on the Zika virus is revealed, researchers are saying that the United States can rest a little easier over concerns of a large-scale outbreak.

An emerging pharmaceutical company has partnered up with the Bill & Melinda Gates Foundation to use its innovative technology to assist in the fight against HIV.

Despite the fact that an increasingly large portion of the hepatitis C (HCV)-infected population successfully achieves a cure for the infection, called sustained viral response (SVR), this population still deals with increased mortality rates.

A new coalition created by the Bill & Melinda Gates Foundation and other global partners will launch at this year’s World Economic Forum, with the goal of supporting the fast-tracked development of new vaccines.

Researchers from the National Institutes of Health recommend integrating men into the family-planning process in the age of Zika.

A new study has revealed more information on how microbes confer resistance to antibiotics.

A new study takes a look at the efficacy of off-label treatments for Clostridium difficile (C. difficile) infection.

Harvoni has been added to Express Script’s formulary and will be available from the company’s Hepatitis Cure Value Program.

Low CD4/CDE8 ratio and a history of bacterial pneumonia heighten the risk for lung cancer in an HIV-positive population.

This year’s most-viewed article on ContagionLive combined two hot-button issues: social media and vaccination.

GlaxoSmithKline recently announced positive results from two recent trials of new antiretroviral drug regimens, showing HIV can be effectively treated with fewer medications.

A new study from University of Copenhagen researchers explains how some multidrug-resistant bacteria are able to survive lethal doses of antibiotics through a hibernation-like defense mechanism.

Researchers use protein misfolding cyclic amplification to screen blood samples for abnormal prions that would indicate Creutzfeldt-Jakob disease (CJD).

Experts suggest government efforts are sorely needed to provide education about HIV/AIDS to at-risk groups, especially among the young gay population.

Researchers from the University of Würzburg in Germany discuss the use of marine natural products to fight drug-resistant pathogens.

Researchers from Australia may have found the key to the spread of antimicrobial-resistant gonorrhea in men who have sex with men (MSM).

A review of the top two video interviews from 2016 is included here.

In Arizona and California, where coccidioidomycosis, or Valley fever, is most prevalent, researchers are putting new federal funding to use to study these fungal infections.

Researchers from Erasmus disease the key factors needed for successful human-to-human contact-transmission of zoonotic pathogens.